Heartsciences Inc. Announces Conversion of Preferred Shares and Debt Exchange, Issuing Over 2.6 Million Shares of Common Stock
HeartSciences Inc. has announced a significant financial update involving the conversion of preferred shares and a debt exchange. As of September 5, 2025, the company reported the receipt of $5.4 million in gross proceeds from its Regulation A Offering, leading to the issuance of 1,556,409 units. Notably, holders of 1,054,549 shares of Series D Preferred Stock have opted to convert their shares into common stock. Additionally, HeartSciences has successfully exchanged $1,805,000 of an unsecured promissory note for 506,348 shares of common stock, effectively reducing the principal amount of the note. Consequently, the total number of common stock shares issued and outstanding now stands at 2,654,540. These strategic financial maneuvers aim to strengthen the company's capital structure and enhance its financial flexibility.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468492-25-000006), on September 08, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.